Effect of alpha1-blockade with doxazosin in pulmonary hypertension associated with cirrhosis
dc.contributor.author | Kalambokis, G. N. | en |
dc.contributor.author | Pappas, K. | en |
dc.contributor.author | Tsianos, E. V. | en |
dc.date.accessioned | 2015-11-24T19:23:06Z | |
dc.date.available | 2015-11-24T19:23:06Z | |
dc.identifier.issn | 1502-7708 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/22247 | |
dc.rights | Default Licence | - |
dc.subject | Adrenergic alpha-1 Receptor Antagonists/*adverse effects/therapeutic use | en |
dc.subject | Aged | en |
dc.subject | Doxazosin/*administration & dosage/therapeutic use | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Hypertension, Pulmonary/complications/*drug therapy | en |
dc.subject | Liver Cirrhosis/complications/drug therapy | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Treatment Outcome | en |
dc.title | Effect of alpha1-blockade with doxazosin in pulmonary hypertension associated with cirrhosis | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.3109/00365521.2010.490951 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/20632812 | - |
heal.identifier.secondary | http://informahealthcare.com/doi/abs/10.3109/00365521.2010.490951 | - |
heal.journalName | Scand J Gastroenterol | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2010 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: